Kairos Pharma KAPA
NYSE KAPA
$0.56 -0.02 (-2.85%)
As of: Oct 22, 2026 · 10:54 AM EDT

Kairos Pharma (KAPA) EBIT (2023 - 2025)

Updated

Kairos Pharma's EBIT came in at -$5.57 million for FY2025, compared with -$2.34 million in FY2024.

Analysis

Kairos Pharma (KAPA) EBIT (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put EBIT at -$2.34 million in FY2024 and -$1.71 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn 7.14 Bn
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn 6.43 Bn
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn 3.16 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 4.27 Bn
10 Kairos Pharma 10.32 Mn -2.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.46 Mn
Mar 31, 2025 -1.27 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -383,000.00
Jun 30, 2024 -222,000.00
Mar 31, 2024 -287,000.00
Dec 31, 2023 -1.09 Mn
Sep 30, 2023 -287,000.00
API Access

Kairos Pharma EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=KAPA&period=max&api_key=YOUR_API_KEY